A combination of the targeted drug vistusertib with paclitaxel chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.
Browsing: ovarian cancer
Research has demonstrated that ovarian cancer patients with a tumor mutation in the BRAF gene respond exceptionally well to BRAF inhibitors.
Researchers have revealed that the use of Lynparza® to treat BRCA-mutated ovarian cancer results in a significant improvement in progression-free survival.
A team of researchers have identified the cause of resistance to breakthrough breast and ovarian cancer drugs.
Researchers from the Case Western Reserve University (OH, USA) have demonstrated how a computer program can suggest novel cancer treatments.
Researchers at Cancer Research UK have discovered a potential combination treatment for glioblastoma, by exploiting leaks in the blood-brain barrier.
Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period
Among other criteria, in this research article from Future Science OA, the authors validated the Gynecological Cancer Intergroup CA125 progression criteria in an ovarian cancer population regarding sensitivity, specificity, positive predictive value and negative predictive value.
This article reviews progress made in the creation of a transplantable artificial ovary and discusses future trends for its development.
Researchers have uncovered a novel method for diagnosing ovarian and breast cancer.